What is the anticipated absolute effect of using ACE-inhibitor in CKD stages 3-4?
The anticipated absolute effect of using ACE-inhibitor in CKD stages 3-4 is very low due to risk of bias and imprecision (from 86 fewer to 18 more). This is according to Table 60: Clinical evidence summary: ACE-inhibitor versus Placebo (CKD stages 3-4) Outcomes in the Treating Heart Failure Chronic Heart Failure NICE 2018 publication, which is subject to Notice of rights and has an ISBN of 978-1-4731-3093-7.